A new trading day began on Monday, with Mersana Therapeutics Inc (NASDAQ: MRSN) stock price down -8.29% from the previous day of trading, before settling in for the closing price of $0.52. MRSN’s price has ranged from $0.48 to $6.28 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 15393.95%. Meanwhile, its annual earnings per share averaged -33.04%. With a float of $85.06 million, this company’s outstanding shares have now reached $115.65 million.
Let’s determine the extent of company efficiency that accounts for 102 employees. In terms of profitability, gross margin is 48.0%, operating margin of -228.07%, and the pretax margin is -212.99%.
Mersana Therapeutics Inc (MRSN) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Mersana Therapeutics Inc is 31.15%, while institutional ownership is 55.11%. The most recent insider transaction that took place on Jan 16 ’25, was worth 2,061. In this transaction VP, Chief Accounting Officer of this company sold 3,554 shares at a rate of $0.58, taking the stock ownership to the 57,519 shares. Before that another transaction happened on Jan 16 ’25, when Company’s Director sold 8,637 for $0.58, making the entire transaction worth $5,009. This insider now owns 168,041 shares in total.
Mersana Therapeutics Inc (MRSN) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -33.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -14.62% during the next five years compared to 2.74% growth over the previous five years of trading.
Mersana Therapeutics Inc (NASDAQ: MRSN) Trading Performance Indicators
Here are Mersana Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.57, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of Mersana Therapeutics Inc (MRSN)
Looking closely at Mersana Therapeutics Inc (NASDAQ: MRSN), its last 5-days average volume was 3.68 million, which is a drop from its year-to-date volume of 7.19 million. As of the previous 9 days, the stock’s Stochastic %D was 13.29%. Additionally, its Average True Range was 0.08.
During the past 100 days, Mersana Therapeutics Inc’s (MRSN) raw stochastic average was set at 0.12%, which indicates a significant decrease from 1.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.97% in the past 14 days, which was lower than the 143.54% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8768, while its 200-day Moving Average is $1.7342. However, in the short run, Mersana Therapeutics Inc’s stock first resistance to watch stands at $0.5133. Second resistance stands at $0.5467. The third major resistance level sits at $0.5633. If the price goes on to break the first support level at $0.4633, it is likely to go to the next support level at $0.4467. Now, if the price goes above the second support level, the third support stands at $0.4133.
Mersana Therapeutics Inc (NASDAQ: MRSN) Key Stats
With a market capitalization of 59.30 million, the company has a total of 123,533K Shares Outstanding. Currently, annual sales are 36,860 K while annual income is -171,670 K. The company’s previous quarter sales were 12,600 K while its latest quarter income was -11,500 K.
